PAGE 22 |
assessment and data col- |
Specific programs are being devel- |
higher risk of having cervical disease |
The only validated swab for self-col- |
with age , reflecting natural immu- |
lation , including participation rates , |
oped to address equity of access for |
than those undergoing routine screen- |
lection in Australia is the red-topped |
nity . Of note is the persistence of low |
|||
rates of HPV infection , and follow-up information .
The register also provides data to
|
Indigenous populations , particularly in rural and remote settings . 11 Programs looking at specific needs in |
ing . Performing the HPV and cytology tests concurrently decreases the risk of either a false-negative HPV result or |
flocked swab ( see figure 8 ). It is vital that this is the only type used , as it is the specific nature of the swab that |
rates of infection with HPV 16 or 18 . The rates of HPV infection in all age groups are higher in the self-col- |
|||
the AIHW for its annual report . 5 |
these communities such as “ see and |
false-negative cytology . |
releases the viral DNA particles appro- |
lection subgroup . |
|||
Participation and equity of access
Even before the 2017 renewal of Aus-
|
treat ” are being investigated .
Australia ’ s understanding of the significance of equity of access and barriers to screening has prompted
|
The sample , therefore , has to be taken from the cervix and collected into a liquid-filled jar .
If the patient is negative for HPV
|
priately into the test analyser .
The only collection device for clinician-collected swabs is the cervix sampler / broom / cytobrush .
|
Rates of detection of abnormalities
The rates of histologically-proven
|
|||
tralia ’ s cervical screening program , |
the introduction of the self-collect |
they return in five years for routine |
Figure 7 outlines the management |
high-grade lesions , stratified by year , |
|||
it was known that participation had |
screening option . |
screening . |
algorithms for the self-collect pathway . |
appear in figure 10 . |
|||
fallen substantially from its peak in the early 2000s .
It is difficult to get an accurate current participation rate . The latest
|
SELF-COLLECT
THE Concept of self-collecting a cervical screening test sample has been
|
If the patient tests positive for HPV 16 or 18 , NCSP guidelines recommend direct referral for colposcopy , where a sample for cervical cytology will be |
Outcomes of self-collection to date
The latest NCSR data since the expan-
|
Notably , there has been a significant increase in detection of high-grade abnormalities since the introduction of HPV testing in Aus- |
|||
figures from the AIHW assess partic- |
understood for many years ; this is now |
taken . Douglass Hanly Moir pathology |
sion of self-collection to all eligible |
tralia ’ s screening program . This |
|||
ipation at 62 % but this number also |
possible because of the highly sensi- |
continues to recommend cytology be |
Australians shows there has been |
was to be expected as it reflects the |
|||
includes people returning for repeat |
tive nature of HPV DNA testing . Some |
done prior to colposcopy , as many col- |
a consistent increase in self-collec- |
higher sensitivity of HPV testing |
|||
HPV testing after a previous positive |
efforts were made to have a self-col- |
poscopists prefer to have the cytology |
tion uptake when analysed by age , |
||||
result . 5 |
lection option for cervical cytology but |
result at the time of examination . |
remoteness index and socio-eco- |
POSITIVE PREDICTIVE VALUE |
|||
Recruitment and participation |
this was never really feasible . |
If the patient tests positive for HPV |
nomic status . Uptake of self-col- |
An important measure in any screen- |
|||
remain a significant issue for the cer- |
International studies , including |
non 16 / 18 , the NCSP recommends the |
lection has also increased among |
ing program is the confirmation |
|||
vical program as some 70 % of cervi- |
meta-analyses , have shown that a |
patient returns to the clinician for a cer- |
under-screened people . In March |
rate of abnormalities . This shows |
|||
cal cancers occur in those who have |
self-collected vaginal test is as sensi- |
vical cytology sample , as management |
2023 the rate was about 20 % of all |
how many patients sent to colpos- |
|||
never been screened . |
tive as a clinician-collected cervical |
depends on the result of the cervical |
samples . 14 |
copy will have a high-grade lesion |
|||
One of the major tasks of the pro- |
HPV test . 12 |
cytology . |
The rate of HPV positivity is sig- |
detected . |
|||
gram is to ensure equity of access |
A self-collection option was ini- |
If the cytology is negative , or |
nificantly higher in self-collected |
AIHW data and work from the |
|||
and elimination of barriers to partic- |
tially included in the protocol for the |
shows possible or low-grade lesions , a |
compared with clinician-collected |
Douglass Hanly Moir laboratory |
|||
ipation . Marginalised and under-ser- |
renewed program in 2017 but was |
repeat HPV test is recommended in 12 |
samples ( 9.72 versus 8.04 , p < 0.001 ). |
show this rate to be 24 %. This is well |
|||
viced groups need to be identified |
restricted to under-screened women |
months ’ time . If the cytology shows a |
Early analysis of this information |
above the internationally accepted |
|||
and targeted for attention . |
older than 30 . The uptake was rela- |
high-grade , glandular or possible high- |
suggests this is because of a higher |
level of 10 % and indicates that the |
|||
Participation rates vary significantly depending on geographic location . These rates reflect the incidence and mortality rates of cervical disease , highlighting the significance of |
tively low .
As previously outlined , increasing the participation rate and providing equity of access to all eligible participants in the screening program is of
|
grade lesions , then a referral directly to colposcopy is indicated .
There has been much discussion as to whether self-testing could be done via mail-out or whether a swab could
|
positivity among under- and never-screened people compared with those previously screened . Unsatisfactory sample rates were higher with self-collection than clini- |
screening program is working well . 15
CASE STUDIES
Case study one
ROMA , a 36-year-old woman , pre-
|
|||
equity of access ( see figure 6 ). |
utmost importance . |
be given to the patient to undertake the |
cian-collection ( 1.98 % versus 0.13 %, |
sents to the GP requesting a sexually |
|||
Consideration of equity of access |
In July 2022 the self-collection |
test at home . |
p < 0.001 ). 14 |
transmitted infection ( STI ) check . |
|||
needs to be given to Indigenous , cul- |
option became available for all people |
For the self-collected test to be as |
Importantly , patients have been |
She is new to the practice . Roma has |
|||
turally and linguistically diverse , and LGBTIQ + communities .
Any patient with , or who has had ,
|
eligible for cervical screening . This option is suitable for both primary screening and as 12-month fol- |
sensitive as the clinician-collected sample , the sampling needs to be done under well-controlled circumstances , |
returning for further investigation at a reasonable rate .
There was about a 70 % rate of
|
recently entered a new relationship with a female partner . She identifies as lesbian and uses the pronoun |
|||
a cervix should have access to and be |
low-up HPV testing where the patient |
with validated swabs , transport and |
colposcopy after a self-collect posi- |
‘ her ’. |
|||
encouraged to participate in cervical |
has tested positive to non 16 / 18 with |
testing . |
tive test for HPV 16 or 18 and about |
Her past medical history is unre- |
|||
screening services . |
negative or low-grade cytology . |
Recently published data from the |
70 % of people returned for a liq- |
markable . She keeps fit and healthy |
|||
Lesbian women report almost half |
It is important to note that a |
Netherlands cervical screening pro- |
uid-base cytology within six months |
with exercise and diet . She has no |
|||
the rates of cervical screening of het- |
self-collected sample cannot be used |
gram - which also offered a self-collect |
of a self-collected non16 / 18 HPV pos- |
symptoms or signs of any STI but , |
|||
erosexual women and account for a |
where a co-test ( simultaneous HPV |
option - showed an uptake of around |
itive result . 14 |
given this is a new relationship , |
|||
much higher proportion of individuals who have never been screened compared with their heterosexual counterparts . 9 , 10 |
and cytology ) is the recommended investigation . The two major clinical situations where this applies are for a symptomatic patient ( potential symp- |
7 % of all samples . 13
Notably , self-collected samples had a significantly lower rate of detection of both HPV and high-grade lesions than
|
Rates of detection of HPV related to age
Recent AIHW data provides an indi-
|
would like to be screened for chlamydia and gonorrhoea .
When the GP asks whether she has ever had any cervical screening tests ,
|
|||
Lesbian and bisexual women |
toms or signs of cervical cancer ) and |
clinician-collected samples , a finding |
cation of the rates of detection of HPV |
Roma advises she had a Pap smear |
|||
and transgender men who have not |
when a patient is undergoing a test of |
contrary to previous studies . |
by subtype ( see figure 9 ). |
10 years ago . She cannot remember |
|||
undergone hysterectomy have been |
cure . |
Detailed analysis shows that the |
The figure is stratified by age and |
the result but found the whole expe- |
|||
specifically included as priority pop- |
A clinician-collected sample is |
collection methodology was causing |
clearly shows the highest rate of |
rience unpleasant and embarrassing |
|||
ulations in both the recent draft Aus- |
needed in each of these cases so that |
the lower sensitivity , highlighting the |
infection is in the younger age group , |
and has not been tested since . Roma |
|||
tralian Cancer Plan and the draft |
an HPV and cytology test can be done |
importance of the collection proce- |
with most infections being the |
has also been told that gay women do |
|||
National Strategy for the Elimination |
concurrently . |
dure . The Netherlands subsequently |
non-vaccine subtypes . |
not need screening . |
|||
of Cervical Cancer in Australia . |
These patients are at significantly |
changed their protocols . |
The rate of infection diminishes |
The GP orders the appropriate |